CABIO(SH:688089) Zheng Quan Zhi Xing·2025-08-29 11:44Core Viewpoint - The company, Jia Bi You Biotechnology (Wuhan) Co., Ltd., has announced the termination of a major asset restructuring and will hold an investor briefing to address investor concerns regarding this decision [1][2]. Group 1: Investor Briefing Details - The investor briefing is scheduled for September 2, 2025, from 16:00 to 17:00 [1][2]. - The briefing will take place at the Shanghai Stock Exchange Roadshow Center and will be conducted in an online text interaction format [1][2]. - Investors can submit questions from August 30, 2025, until September 2, 2025, at 14:00 through the Roadshow Center website or via the company's email [3]. Group 2: Company Actions - The company’s board and supervisory board have approved the termination of the asset restructuring and the withdrawal of related application documents [1]. - The company will sign a termination agreement with the transaction counterparties as part of this process [1]. Group 3: Participants in the Briefing - Key participants in the investor briefing will include the company's Chairman and General Manager, the Board Secretary, representatives from the transaction counterparties, and independent financial advisors [2]. Group 4: Contact Information - For inquiries, investors can contact Wang Fang at phone number 027-67845289 or via email at zqb@cabio.cn [4].